Skip to main content
. 2017 Dec 12;118(1):17–23. doi: 10.1038/bjc.2017.379

Figure 3.

Figure 3

Recurrence-free survival of triple-negative breast cancer 5-year survivors as function of hormone receptor positivity and time from diagnosis. ER=oestrogen receptor; PR=progesterone receptor.